How to buy Repligen Corporation stock (RGEN)

Repligen Corporation is a medical instruments & supplies business based in the US. Repligen Corporation shares (RGEN) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $147.34 – a decrease of 5.55% over the previous week. Repligen Corporation employs 1,783 staff and has a trailing 12-month revenue of around $639.9 million.

Our top picks for where to buy Repligen Corporation stock

Buy Repligen Corporation stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Repligen Corporation stock price (NASDAQ: RGEN)

Use our graph to track the performance of RGEN stocks over time.

Repligen Corporation shares at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$147.34
52-week range	$113.50 - $211.13
50-day moving average more info button	$143.32
200-day moving average more info button	$151.94
Wall St. target price	$191.46
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.03

Is it a good time to buy Repligen Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Repligen Corporation price performance over time

Historical closes compared with the close of $158.14 from 2024-12-17

1 week (2024-12-12)	1.38%
1 month (2024-11-20)	13.85%
3 months (2024-09-19)	8.48%
6 months (2024-06-18)	28.57%

1 year (2023-12-19)	-13.16%
2 years (2022-12-19)	-2.64%
3 years (2021-12-17)	265.42
5 years (2019-12-19)	75.17%

Is Repligen Corporation stock undervalued or overvalued?

Valuing Repligen Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Repligen Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Repligen Corporation's PEG ratio

Repligen Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.59. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Repligen Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Repligen Corporation's EBITDA

Repligen Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $100.5 million.

The EBITDA is a measure of a Repligen Corporation's overall financial performance and is widely used to measure a its profitability.

Repligen Corporation financials

Revenue TTM	$639.9 million
Gross profit TTM	$455.7 million
Return on assets TTM	0.2%
Return on equity TTM	-0.1%
Profit margin	-0.33%
Book value	$35.53
Market Capitalization more info button	$8.3 billion

TTM: trailing 12 months

Repligen Corporation share dividends

We're not expecting Repligen Corporation to pay a dividend over the next 12 months.

Repligen Corporation share price volatility

Over the last 12 months, Repligen Corporation's shares have ranged in value from as little as $113.5 up to $211.13. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Repligen Corporation's is 0.959. This would suggest that Repligen Corporation's shares are less volatile than average (for this exchange).

Repligen Corporation overview

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations.

Frequently asked questions

What percentage of Repligen Corporation is owned by insiders or institutions?
Currently 6.582% of Repligen Corporation shares are held by insiders and 100.698% by institutions. How many people work for Repligen Corporation?
Latest data suggests 1,783 work at Repligen Corporation. When does the fiscal year end for Repligen Corporation?
Repligen Corporation's fiscal year ends in December. Where is Repligen Corporation based?
Repligen Corporation's address is: Building 1, Waltham, MA, United States, 02453 What is Repligen Corporation's ISIN number?
Repligen Corporation's international securities identification number is: US7599161095 What is Repligen Corporation's CUSIP number?
Repligen Corporation's Committee on Uniform Securities Identification Procedures number is: 759916109